U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7
- PMID: 16368889
- DOI: 10.1182/blood-2005-07-2650
U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7
Erratum in
- Blood. 2006 May 15;107(10):3831
Abstract
Plasmacytoid dendritic cells (PDCs), which produce IFN-alpha in response to autoimmune complexes containing nuclear antigens, are thought to be critically involved in the pathogenesis of systemic lupus erythematosus (SLE). One of the immunostimulatory components of SLE immune complexes (SLE-ICs) is self DNA, which is recognized through Tlr9 in PDCs and B cells. Small nuclear ribonucleoproteins (snRNPs) are another major component of SLE-ICs in 30% to 40% of patients. In this study, we show that murine PDCs are activated by purified U1snRNP/anti-Sm ICs to produce IFN-alpha and proinflammatory cytokines and to up-regulate costimulatory molecules. The induction of IFN-alpha and IL-6 by U1snRNPs in murine bone marrow-derived PDCs required the presence of intact U1RNA and was largely dependent on Tlr7 but independent of Tlr3. Intracellularly delivered isolated U1snRNA and oligoribonucleotides derived from the stem loop regions and the Sm-binding site of U1snRNA efficiently induced IFN-alpha and IL-6 in Flt3L-cultured DCs in a Tlr7-dependent manner. The U1snRNA component of U1snRNP immune complexes, found in patients with SLE, acts as an endogenous "self" ligand for Tlr7 and triggers IFN-alpha and IL-6 production in PDCs.
Similar articles
-
Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.Front Immunol. 2018 Aug 28;9:1957. doi: 10.3389/fimmu.2018.01957. eCollection 2018. Front Immunol. 2018. PMID: 30210502 Free PMC article. Clinical Trial.
-
C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes.Arthritis Rheum. 2013 Jul;65(7):1891-901. doi: 10.1002/art.37968. Arthritis Rheum. 2013. PMID: 23576062 Free PMC article.
-
TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.Clin Immunol. 2008 Oct;129(1):40-8. doi: 10.1016/j.clim.2008.06.004. Epub 2008 Aug 5. Clin Immunol. 2008. PMID: 18684674
-
Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.Ann N Y Acad Sci. 2005 Dec;1062:242-51. doi: 10.1196/annals.1358.027. Ann N Y Acad Sci. 2005. PMID: 16461805 Review.
-
Emerging roles of TLR7 and TLR9 in murine SLE.J Autoimmun. 2009 Nov-Dec;33(3-4):231-8. doi: 10.1016/j.jaut.2009.10.001. Epub 2009 Oct 21. J Autoimmun. 2009. PMID: 19846276 Review.
Cited by
-
Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway.Clin Transl Immunology. 2016 May 13;5(5):e79. doi: 10.1038/cti.2016.26. eCollection 2016 May. Clin Transl Immunology. 2016. PMID: 27350879 Free PMC article. Review.
-
Candidate genes of SARS-CoV-2 gender susceptibility.Sci Rep. 2021 Nov 9;11(1):21968. doi: 10.1038/s41598-021-01131-7. Sci Rep. 2021. PMID: 34753980 Free PMC article.
-
CD72 is a Negative Regulator of B Cell Responses to Nuclear Lupus Self-antigens and Development of Systemic Lupus Erythematosus.Immune Netw. 2019 Feb 13;19(1):e1. doi: 10.4110/in.2019.19.e1. eCollection 2019 Feb. Immune Netw. 2019. PMID: 30838156 Free PMC article. Review.
-
EGF-Receptor-Dependent TLR7 Signaling in Macrophages Promotes Glomerular Injury in Crescentic Glomerulonephritis.Lab Invest. 2023 Sep;103(9):100190. doi: 10.1016/j.labinv.2023.100190. Epub 2023 Jun 1. Lab Invest. 2023. PMID: 37268107 Free PMC article.
-
Yaa autoimmune phenotypes are conferred by overexpression of TLR7.Eur J Immunol. 2008 Jul;38(7):1971-8. doi: 10.1002/eji.200838138. Eur J Immunol. 2008. PMID: 18521959 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases